Form 4 for ASH ASHLAND INC.
Accepted 2025-11-17 00:00:00 ET · period of report 2025-11-13 · accession 0001193125-25-285057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-17 | 2025-11-13 | ASH | Assis Alessandra Faccin | SVP, GM, Life Sciences | F - Tax | $53.10 | -570 | 5,716 | -9% | -$30.3K |
| D | 2025-11-17 | 2025-11-13 | ASH | Assis Alessandra Faccin | SVP, GM, Life Sciences | M - OptEx | $53.10 | +1,340 | 6,286 | +27% | +$71.2K |
| D | 2025-11-17 | 2025-11-13 | ASH | Assis Alessandra Faccin | SVP, GM, Life Sciences | M - OptEx | $0.00 | -1,340 | 2,680 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-13 | F | D | 570 | $53.10 | 5,716 | D | — | — | (F1) Payment of tax liability by withholding securities incident to the vesting of Restricted Stock Units acquired pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. |
| 2 | Common | Common Stock | 2025-11-13 | M | A | 1,340 | $53.10 | 6,286 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2025-11-13 | M | D | 1,340 | $0.00 | 2,680 | D | — · — to — | 1,340 Common Stock | (F4) Balance includes additional restricted stock units acquired in lieu of cash dividends. (F2) Each Restricted Stock Unit represents a right to receive one (1) share of Ashland Common Stock. (F3) Grant of Restricted Stock Units pursuant to Ashland's incentive plan as approved by the shareholders and exempt pursuant to Rule 16b-3. The shares in this grant vest in three equal installments beginning one year from the date of grant, provided that the Reporting Person remains in continuous employment with the Issuer. |